Close
ACHEMA MIDDLE EAST 2026

CEPiA Peptides and Oligonucleotides

AI Summary

PEPTIDES & OLIGONUCLEOTIDES
From a unique state-of-the-art platform for development and scale-up of Peptides in Frankfurt (Germany) and Oligonucleotides in Frankfurt (Germany) & Haverhill (United Kingdom), CEPiA offers customized services (manufacturing and analytical) and can provide the full scope of development activities from clinical phase up to submission and launch, including regulatory support, as well as commercial supplies.

For more information Click Here

CEPIA SANOFI

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES